Bridging health inequality on our shores

Maluk Timor

Maluk Timor is a not-for-profit organisation that aims to help Timor-Leste beat its largest health issues.  The young country has made great improvements since its establishment 11 years ago, but is still desperately in need of additional support to improve the quality of life of its citizens. It is a shocking example of stark medical inequality right on Australia’s shores (only 700km away!), and one that TIME is committed to changing.

Maluk Timor provides free and essential medical services to over 300 Timorese people every day. Care ranges from preventative vaccines and antenatal screens to emergency treatment for life-threatening conditions such as infection and trauma. It also provides support to rural areas through mobile outreach activities. Established in 2017 Maluk Timor is predominantly supported by the generosity of private donors. It is persistently underfunded, and has critical need for further support to meet the basic health needs of the people of Timor-Leste. On some days there is not even enough paracetamol or penicillin to treat patients – a situation that is unimaginable to us here in Australia!


Ending Tuberculosis (TB)

Timor-Leste has one of the highest rates of TB in Asia, with half of all active cases remaining undiagnosed. Maluk Timor healthcare workers operate in the community to find cases of TB and facilitate preventative treatment.


Preventing Spread of HIV/Aids

Maluk Timor currently cares for the largest cohort of patients in Timor-Leste. Timor-Leste is regarded as a country with a low prevalence of HIV, with limited data estimating it exists in 1% of the Dili population. However, the spread of HIV/AIDs would be lethal for Timorese people – as many who are silently infected with TB would go on to develop life-threatening illness with an HIV co-infection.

In Australia, we now live in a time where being HIV+ is NOT a death-sentence. But rather, most PLHIV go on to live happy, healthy and productive lives, with the appropriate anti-retroviral treatment. This is far from the case in Timor-Leste. Less than 50% of PLHIV in Timor-Leste currently receive treatment for HIV/AIDs, resulting in a high mortality rate from this highly escapable disease.  


For more information about Maluk Timor, visit their website!




Attend our Fundraisers

TIME runs annual fundraisers for Maluk Timor, in our bid to raise money to support their core health programs. The money raised goes to meeting locally-identified needs such as employing HIV/AIDs counsellors. 

The largest of the fundraising events is the the Kick Off Party that occurs at the start of each year, and is a fantastic opportunity to mingle with other TIME members whilst donating the ticket price to this important cause.

We encourage you to take one of many opportunities to use your time and dollars to contribute to improving health outcomes in Timor-Leste!


Our monetary support to Maluk Timor is extremely valued, particularly for its consistency and flexibility. However it remains modest in amount, given the many causes we support as an organisation. TIME is seeking long-term sponsors to help boost the support we offer to Maluk Timor. 

If you or your organisation would like to sponsor any of our events or otherwise support the clinic, please get in touch with our Sponsorship Officer for more information on how to do so.

Maluk Timor Elective

This is an opportunity open to all TIME medical and allied health students (including first-year medical observership) with an interest in global health. 

Two successful applicants will have the chance to fundraise and undergo a 4-week elective with Maluk Timor, helping to deliver free medical are to the local community. 

The elective is a unique and challenging opportunity to learn about global medicine and healthcare delivery in a low-resource context. It also strengthens TIME’s partnership with Maluk Timor and helps build understanding and awareness of the difficulties faced them, so that we are able to optimally respond to their needs in future years.